BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7222314)

  • 21. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The composition of four-hour urine samples from patients with calcium oxalate stone disease.
    Berg C; Larsson L; Tiselius HG
    Br J Urol; 1987 Oct; 60(4):301-6. PubMed ID: 3690199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary glycosaminoglycan excretion in urolithiasis.
    Akçay T; Konukoğlu D; Dínçer Y
    Arch Dis Child; 1999 Mar; 80(3):271-2. PubMed ID: 10325710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seasonal variation in urinary excretion of calcium, oxalate, magnesium and phosphate on free and standard mineral diet in men with urolithiasis.
    Juuti M; Heinonen OP; Alhava EM
    Scand J Urol Nephrol; 1981; 15(2):137-41. PubMed ID: 7330607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects.
    Siener R; Hesse A
    Eur Urol; 2002 Sep; 42(3):289-96. PubMed ID: 12234515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients.
    Ebisuno S; Morimoto S; Yasukawa S; Ohkawa T
    Br J Urol; 1991 Mar; 67(3):237-40. PubMed ID: 1902388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the severity of renal stone disease and urine composition.
    Tiselius HG
    Eur Urol; 1979; 5(5):323-7. PubMed ID: 446508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
    Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy).
    De Santo NG; Di Iorio B; Capasso G; Paduano C; Stamler R; Langman CB; Stamler J
    Pediatr Nephrol; 1992 Mar; 6(2):149-57. PubMed ID: 1571211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients Attending Shared Medical Appointments for Metabolic Stone Prevention Have Decreased Stone Risk Factors.
    Jhagroo RA; Nakada SY; Penniston KL
    J Endourol; 2016 Nov; 30(11):1262-1268. PubMed ID: 27673722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on calcium oxalate crystal formation in urolithiasis. Multi-regressive analysis of urinary CaOx crystalline volumes and the effects of urinary various substances on CaOx crystal formation].
    Kataoka K; Umekawa T; Katayama Y; Ishikawa Y; Kodama M; Takamura C; Takada M; Kato Y; Hohri K; Iguchi M
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):799-803. PubMed ID: 1875573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of calcium oxalate crystal growth in urine during treatment with allopurinol.
    Tiselius HG
    Br J Urol; 1980 Jun; 52(3):189-92. PubMed ID: 7426978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methodological aspects of examination of 24 hour urinary excretions in outpatients with recurrent urolithiasis.
    Laerum E; Palmer H
    Scand J Urol Nephrol; 1983; 17(3):321-4. PubMed ID: 6648379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of calcium treatment on urinary stone index after intestinal bypass for obesity.
    Holm CN; Hessov I
    Digestion; 1981; 22(5):255-8. PubMed ID: 7308596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Magnesium excretion in recurrent calcium urolithiasis].
    Pfab R; Hegemann M; Schütz W; Böttger I
    Urologe A; 1985 Sep; 24(5):296-8. PubMed ID: 4060380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.
    Trinchieri A; Lizzano R; Marchesotti F; Zanetti G
    Urol Res; 2006 Feb; 34(1):1-7. PubMed ID: 16425021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium excretion and calcium oxalate urolithiasis.
    Resnick MI; Munday D; Boyce WH
    Urology; 1982 Oct; 20(4):385-9. PubMed ID: 7147507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.
    Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A
    Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.